Miltenyi Biotec, Inc.
910 Clopper Rd #200
Gaithersburg
Maryland
20878
United States
About Miltenyi Biotec, Inc.
Miltenyi Biotec is a global leader in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cutting-edge cell and gene therapy. Starting with our proprietary magnetic-activated cell sorting (MACS) Technology, Miltenyi provides an innovative portfolio of cellular technologies that can be seamlessly used in a variety of research, translational, and clinical applications.
Our mission is to make cancer history. At Miltenyi Biotec, engineers, scientists, software developers, and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians.
Everyone at Miltenyi Biotec is committed to making cancer history. Watch the video to see what motivates our scientists, engineers, IT professionals, and marketeers. Learn why they like working at Miltenyi Biotec.
18 articles with Miltenyi Biotec, Inc.
-
IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note
9/26/2019
IsoPlexis illustrates progress in CAR-T development & bioprocessing with funding, recent data sets, and co-marketing technology note with Miltenyi Biotec, Inc.
-
Cellenion and Miltenyi Biotec Sign Co-Marketing Agreement to Provide a Time and Cost-Efficient Solution for the Development of Monoclonal Cell Lines
7/12/2018
SCIENION AG and Miltenyi Biotec GmbH today announced that Scienion’s affiliate Cellenion and Miltenyi Biotec have signed a co-marketing agreement.
-
Lentigen Technology, A Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma
7/20/2017
-
After Filling 70 U.S. Positions This Year, Miltenyi Biotec Plans to Add 30 More U.S. Jobs in 2017
12/2/2016
-
Miltenyi Biotec, Inc. Webinar Spotlights Advances In Translational And Basic T Cell Research
6/14/2016
-
Miltenyi Biotec, Inc. And Cesca Therapeutics' Subsidiary Totipotentrx Announce Multi-Year Commercial Agreement For Bone Marrow Transplantation
10/28/2015
-
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation
8/14/2014
-
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia
1/24/2014
-
Miltenyi Biotec, Inc. Acquires Owl biomedical, Inc.
4/23/2013
-
Miltenyi Biotec, Inc. Partners With Terso Solutions, Inc. for a Fully Automated, On-Site Inventory Management Program
4/3/2013
-
Automated Cell Biology Workflows with Tecan And Miltenyi Biotec, Inc.
8/17/2010
-
Miltenyi Biotec, Inc.: Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
10/29/2009
-
Miltenyi Biotec, Inc.'s Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
7/14/2009
-
Miltenyi Biotec, Inc.'s Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings
5/20/2009
-
Miltenyi Biotec, Inc. Release: The New MACSQuant(TM) Analyzer Combines Cell Enrichment and Flow Cytometry
1/16/2009
-
Miltenyi Biotec, Inc. Acquires Medic Tools AG
6/10/2008
-
Miltenyi Biotec, Inc. 2006 Frost & Sullivan European Life Sciences And Pharmaceuticals Product Innovation Of The Year Award
2/15/2007
-
PLC Medical Systems And Miltenyi Biotec, Inc. Sponsor Presentation On Stem Cell Therapy In Cardiac Surgery
9/25/2006